Facebook Twitter LinkedIn YouTube Instagram

To navigate the following site navigation expect to utilize the tab key to move through items sequentially. The spacebar or enter keys can be utilized to interact with items that open sub-navigation.

The next tab will be the search box toggle. Hit enter to open the search, focus will automatically shift to the search bar. Type a letter into the search input and suggested results will appear.

Drug

H01

Status:

Phase 2

Condition:

Pulmonary Hypertension

Intervention Type:

Oral Drug

Funder Type:

Organization | University

Drug Details

H01 (Hymecromone) is an oral drug approved in Europe for biliary spasm treatment.

Study Purpose

This study is a prospective, randomized, double-blind, study of H01 (Hymecromone) in adults with pulmonary hypertension (PH). The primary objective of this study is to evaluate the safety and tolerability of oral H01 and the potential benefit of oral H01 on clinical measures of PH disease severity over 24 weeks.

Find a Clinical Trial